Rate of adverse events low; benefits of the vaccine still outweigh risks in most situations, say researchers A large study from Denmark and Norway published by The BMJ today sheds more light on the risk of rare blood clots in adults receiving their first dose of the Oxford-AstraZeneca covid-19 vaccine. The findings show slightly increased rates of … Continue reading Study sheds more light on rate of rare blood clots after Oxford-AstraZeneca vaccine